Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?

被引：33

作者：

Schiavi, Michele Carlo ^{[1
]}

Sciuga, Valentina ^{[1
]}

Giannini, Andrea ^{[1
]}

Vena, Flaminia ^{[1
]}

D'oria, Ottavia ^{[1
]}

Prata, Giovanni ^{[1
]}

Di Tucci, Chiara ^{[1
]}

Savone, Delia ^{[1
]}

Aleksa, Natalia ^{[1
]}

Capone, Carmela ^{[1
]}

Di Mascio, Daniele ^{[1
]}

Meggiorini, Maria Letizia ^{[1
]}

Monti, Marco ^{[1
]}

Zullo, Marzio Angelo ^{[2
]}

Muzii, Ludovico ^{[1
]}

Panici, Pierluigi Benedetti ^{[1
]}

机构：

[1] Univ Rome Sapienza, Umberto Hosp 1, Dept Gynecol & Obstetr Sci & Urol Sci, Viale Policlin 155, I-00161 Rome, Italy

[2] Univ Rome, Dept Surg Week Surg, Campus Biomed, Rome, Italy

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 2018年 / 34卷 / 08期

关键词：

Vulvovaginal atrophy; overactive bladder syndrome; ospemifene; sexual function; quality of life; POSTMENOPAUSAL WOMEN; GENITOURINARY SYNDROME; URINARY-INCONTINENCE; ESTROGEN; HEALTH; DYSPAREUNIA; VALIDATION; EFFICACY; IMPACT;

D O I：

10.1080/09513590.2018.1441398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this study was to assess the effectiveness of ospemifene in the improvement of sexual function in postmenopausal women with vulvovaginal atrophy (VVA) affected by overactive bladder syndrome (OAB) or urge urinary incontinence (UUI). One hundred five postmenopausal patients with VVA affected by OAB and/or UUI were enrolled for the study. All patients received ospemifene 60mg for 12 weeks. Clinical examination, 3-d voiding diary and the vaginal health index (VHI) were performed at baseline and at 12 weeks. Patients completed the OAB-Q SF, FSFI, FSDS, and SF-36 questionnaires. The patient's satisfaction was also calculated. After 12 weeks, the reduction of urinary symptoms was observed. The OAB-Q symptoms, OAB-Q (HRQL) score were (55.34 +/- 13.54 vs. 23.22 +/- 9.76; p<.0001) and (22.45 +/- 9.78 vs. 70.56 +/- 15.49; p<.0001), before and after treatment. SF-36 questionnaire showed a significant improvement (p < .0001). VHI score increased and the women who regularly practice sexual activity increased after treatment. The total FSFI score increased significantly and the FSDS score changed after 12 weeks (p < .0001). The PGI-I after 12 weeks showed a total success rate of 90.5%. Ospemifene is an effective potential therapy for postmenopausal women with VVA affected by OAB or UUI improving sexual function and quality of life.

引用

页码：666 / 669

页数：4

共 28 条

[21]

Robinson Dudley, 2013, Menopause Int, V19, P155, DOI 10.1177/1754045313511398

[22] A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life [J].

Schiavi, M. C. ;

Di Tucci, C. ;

Colagiovanni, V. ;

Faiano, P. ;

Giannini, A. ;

D'Oria, O. ;

Prata, G. ;

Perniola, G. ;

Monti, M. ;

Zullo, M. A. ;

Muzii, L. ;

Panici, P. Benedetti .

LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (02) :O11-O15

[23] Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms [J].

Schiavi, Michele Carlo ;

Zullo, Marzio Angelo ;

Faiano, Pierangelo ;

D'Oria, Ottavia ;

Prata, Giovanni ;

Colagiovanni, Vanessa ;

Giannini, Andrea ;

Di Tucci, Chiara ;

Perniola, Giorgia ;

Di Donato, Violante ;

Monti, Marco ;

Muzii, Ludovico ;

Panici, Pierluigi Benedetti .

GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (12) :942-945

[24] Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients [J].

Schiavi, Michele Carlo ;

Perniola, Giorgia ;

Di Donato, Violante ;

Visentin, Virginia Sibilla ;

Vena, Flaminia ;

Di Pinto, Anna ;

Zullo, Marzio Angelo ;

Monti, Marco ;

Panici, Pierluigi Benedetti .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (04) :917-922

[25] The psychosocial impact of urinary incontinence in women [J].

Sinclair, Amy J. ;

Ramsay, Ian N. .

OBSTETRICIAN & GYNAECOLOGIST, 2011, 13 (03) :143-148

[26] PGI-I (Patient's Global Impression) as an Outcome and Quality Indicator of Psychiatric In-patient Treatment: Results and Concordance with Doctor's Assessments [J].

Steinert, Tilman ;

Eisele, Frank ;

Laengle, Gerhard ;

Albani, Cornelia ;

Flammer, Erich ;

Borbe, Raoul .

PSYCHIATRISCHE PRAXIS, 2010, 37 (07) :343-349

[27] Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results [J].

Visco, AG ;

Wei, JT ;

McClure, LA ;

Handa, VL ;

Nygaard, IE .

INTERNATIONAL UROGYNECOLOGY JOURNAL AND PELVIC FLOOR DYSFUNCTION, 2003, 14 (02) :136-140

[28] The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study [J].

Weber, Maaike A. ;

Lim, Veronica ;

Oryszczyn, Josephine ;

te West, Nevine ;

Souget, Judith ;

Jeffery, Stephen ;

Roovers, Jan Paul W. R. ;

Moore, Kate H. .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2017, 82 (01) :15-21

← 1 2 3 →